Shares of Lupin Ltd reach all-time high price on acquiring …
5 days ago · Shares of Lupin Ltd surged 2.38 per cent to ₹2,364.65 on the BSE at 11.27 AM and it reached an all-time high of ₹2,372.55 during the session.. Lupin Ltd., a global pharmaceutical company ...
Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug ...
6 days ago · Home / Markets / News / Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug ... Lupin's management believes the company’s product pipeline for the US in FY26 will increase US sales to $1 billion in CC terms. Hence, the brokerage firm expects Lupin’s sales to grow at a compound annual growth rate (CAGR) of 9 per cent and earnings ...
Lupin Acquires Huminsulin from Lilly to Enhance Diabetes Portfolio - Lupin
Mumbai, December 30, 2024: Global pharma major Lupin Limited (Lupin) announced today the acquisition of Huminsulin® in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio.Lupin has been marketing the Huminsulin range of products comprising of Insulin Human, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, and Huminsulin 30/70, through existing ...
Lupin Announcement, Latest News on Lupin - The Economic Times
Dec 27, 2024 · Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US market, a significant boost for the company.
LUPN.NS - | Stock Price & Latest News | Reuters
5 days ago · Get Lupin Ltd (LUPN.NS) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio
5 days ago · Lupin Limited. (Image Credits: FE.com) ... Download the Financial Express App for the latest finance news. First published on: 31-12-2024 at 12:47 IST . Stock Market Stats. Market Stats.
Lupin : December 13, 2024 Lupin Acquires 3 Trademarks from …
Mumbai, December 13, 2024: Global pharma major Lupin Limited (Lupin) announced today the acquisition of anti-diabetes trademarks GIBTULIO®, GIBTULIO MET® and AJADUO® from Boehringer Ingelheim International GmbH (Boehringer Ingelheim), to strengthen its diabetes portfolio in the country.
Lupin Ltd | Reuters
Aug 7, 2024 · Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its …
Lupin Shares Hit Life High Following Huminsulin Acquisition
6 days ago · Shares of Lupin Ltd. surged by 1.34% on Tuesday, reaching all-time high after the company announced the acquisition of Huminsulin in India from Eli Lilly and Co. The acquisition is a move towards enhancing Lupin’s diabetes portfolio, although the financial terms of the deal were not disclosed. Lupin had previously marketed Huminsulin products, including Huminsulin R, Huminsulin NPH, and ...
Lupin shares zoom up to 15% in last 2 weeks. Analysts predict …
3 days ago · Lupin shares continue to rise, trading at a new 52-week high of Rs 2,376 after a 15% return over two weeks. The Nifty Pharma index's December outperformance highlights buying interest in pharma stocks amid market uncertainty. Analysts recommend buying on dips towards Rs 2,300 with targets around Rs 2,500 as bullish patterns and strong market share bolster Lupin's investment appeal.